课题基金 / 基金详情

Disabling the replication-competent HIV provirus in the reservoir by combined CRISPR-Cas action

Disabling the replication-competent HIV provirus in the reservoir by combined CRISPR-Cas action
通过 CRISPR-Cas 联合作用使储存库中具有复制能力的 HIV 原病毒失效
批准号:
10620836
负责人:
Benjamin Berkhout
金额:
$50.66万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-04-05 至 2024-03-31

项目摘要

项目成果

Benjamin Berkhout的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Summary. DNA can be targeted by the CRISPR- Cas (CC) genome editing tool, which was swiftly implemented in anti-HIV studies1-8. We confirmed potent HIV inhibition, but also demonstrated rapid virus escape from CC attack9. Inspection of the escape viruses indicated a role of the NHEJ enzyme, which repairs dsDNA breaks and introduces small insertions/deletions (indels) in the process. In other words, we described a novel viral escape route that is facilitated by a cellular DNA repair process. These results were confirmed by other labs10-21. A combinatorial CC attack against conserved sequences triggered HIV inactivation through hypermutation, quite different from the proposed excision route (Fig 1). Although provirus excision could be detected in our system, it occurred with a very low efficiency. Instead, CC attack generated hypermutated proviruses that apparently lost all replication potential. In other words, continuous CC action can functionally CURE HIV infected cells, leaving the cells with a graveyard of inactivated HIV proviruses. This surprise finding represents a major hallmark in HIV CURE studies. We now propose to first delineate the underlying mechanisms and variables that determine the outcome of CC attack (HIV excision versus hypermutation). This will allow us to formulate the best CURE strategy. At the same time we focus on the major obstacle towards a CURE: delivery of the gene therapeutics to cells that compose the HIV-reservoir. The CC and delivery tools will then be combined for in vivo CURE studies in the HIS mouse.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.jbc.2023.104743
发表时间: 2023-06
期刊: JOURNAL OF BIOLOGICAL CHEMISTRY
影响因子: 4.8
作者: [Riechert, Vanessa, Hein, Sascha, Visser, Mayken, Zimmermann, Mathias, Wesche, Jan, Adams, Philipp A, Theuerkauf, Samuel A, Jamali, Arezoo, Wangorsch, Andrea, Reuter, Andreas, Pasternak, Alexander O, Hartmann, Jessica, Greinacher, Andreas, Herrera-Carrillo, Elena, Berkhout, Ben, Cichutek, Klaus, Buchholz, Christian J]
通讯作者: Buchholz, Christian J
DOI: 10.1007/978-1-0716-0716-9_12
发表时间: 2021
期刊: Methods in molecular biology (Clifton, N.J.)
影响因子: --
作者: [Berkhout B, Gao Z, Herrera-Carrillo E]
通讯作者: Herrera-Carrillo E
DOI: 10.1074/jbc.ra120.015386
发表时间: 2021-01
期刊: The Journal of biological chemistry
影响因子: --
作者: [Gao Z, van der Velden YU, Fan M, van der Linden CA, Vink M, Herrera-Carrillo E, Berkhout B]
通讯作者: Berkhout B
Disabling the replication-competent HIV provirus in the reservoir by combined CRISPR-Cas action
  • 批准号:
    9908049
  • 项目类别:
  • 资助金额:
    $52.47万
  • 财政年份:
    2019
  • 负责人:
    Benjamin Berkhout
  • 依托单位:
Disabling the replication-competent HIV provirus in the reservoir by combined CRISPR-Cas action
  • 批准号:
    10458467
  • 项目类别:
  • 资助金额:
    $53.7万
  • 财政年份:
    2019
  • 负责人:
    Benjamin Berkhout
  • 依托单位:
Disabling the replication-competent HIV provirus in the reservoir by combined CRISPR-Cas action
  • 批准号:
    9753408
  • 项目类别:
  • 资助金额:
    $53.42万
  • 财政年份:
    2019
  • 负责人:
    Benjamin Berkhout
  • 依托单位:
MINI-HIV VARIANTS AS LIVE-ATTENUATED VACCINE STRAIN
  • 批准号:
    6374429
  • 项目类别:
  • 资助金额:
    $15.0万
  • 财政年份:
    2000
  • 负责人:
    Benjamin Berkhout
  • 依托单位:
海外基金